Publications
Filters: Keyword is Female [Clear All Filters]
“International gestational age-specific centiles for umbilical artery Doppler indices: a longitudinal prospective cohort study of the INTERGROWTH-21(st) Project”, Am J Obstet Gynecol, vol. 222, no. 6, pp. 602 e1-602 e15, 2020.
, “Image-scoring system for umbilical and uterine artery pulsed-wave Doppler ultrasound measurement”, Ultrasound Obstet Gynecol, vol. 53, no. 2, pp. 251-255, 2019.
, “The impact of targeted malaria elimination with mass drug administrations on falciparum malaria in Southeast Asia: A cluster randomised trial”, PLoS Med, vol. 16, no. 2, p. e1002745, 2019.
, “Maternal Hepatitis B Infection Burden, Comorbidity and Pregnancy Outcome in a Low-Income Population on the Myanmar-Thailand Border: A Retrospective Cohort Study”, J Pregnancy, vol. 2019, p. 8435019, 2019.
, “Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children”, Nat Commun, vol. 10, no. 1, p. 480, 2019.
, “The role of monitoring and evaluation to ensure functional access to community-based early diagnosis and treatment in a malaria elimination programme in Eastern Myanmar”, Malar J, vol. 18, no. 1, p. 50, 2019.
, “Spatiotemporal epidemiology, environmental correlates, and demography of malaria in Tak Province, Thailand (2012-2015)”, Malar J, vol. 18, no. 1, p. 240, 2019.
, “Antimalarial drugs for treating and preventing malaria in pregnant and lactating women”, Expert Opin Drug Saf, vol. 17, no. 11, pp. 1129-1144, 2018.
, “Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression”, Eur J Haematol, vol. 100, no. 3, pp. 294-303, 2018.
, “Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study”, Malar J, vol. 17, no. 1, p. 427, 2018.
, “Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice”, Med Microbiol Immunol, vol. 207, no. 5-6, pp. 271-286, 2018.
, “Genotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malaria”, Malar J, vol. 16, no. 1, p. 134, 2017.
, “Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border”, J Infect Dis, vol. 215, no. 3, pp. 396-404, 2017.
, “Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?”, Expert Opin Drug Saf, vol. 15, no. 3, pp. 367-82, 2016.
, “Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests”, Am J Trop Med Hyg, vol. 92, no. 4, pp. 818-24, 2015.
, “Dense genomic sampling identifies highways of pneumococcal recombination”, Nat Genet, vol. 46, no. 3, pp. 305-9, 2014.
, “Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast”, Infect Immun, vol. 82, no. 3, pp. 1296-1307, 2014.
, “Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda”, J Antimicrob Chemother, vol. 69, no. 11, pp. 3033-40, 2014.
, “Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria”, Clin Infect Dis, vol. 56, no. 5, pp. e48-58, 2013.
, “Malaria in the post-partum period; a prospective cohort study”, PLoS ONE, vol. 8, no. 3, p. e57890, 2013.
, “Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants”, J Infect Dis, vol. 207, no. 11, pp. 1646-54, 2013.
, “Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture”, Int J Parasitol, vol. 42, no. 2, pp. 155-60, 2012.
, “Effect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986-2010”, PLoS ONE, vol. 7, no. 7, p. e40244, 2012.
, “The epidemiology of postpartum malaria: a systematic review”, Malar J, vol. 11, p. 114, 2012.
, “Micronutrient status in lactating mothers before and after introduction of fortified flour: cross-sectional surveys in Maela refugee camp”, Eur J Nutr, vol. 51, no. 4, pp. 425-34, 2012.
, “Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria”, Antimicrob Agents Chemother, vol. 56, no. 4, pp. 1997-2007, 2012.
, “Pyronaridine-artesunate versus mefloquine plus artesunate for malaria”, N Engl J Med, vol. 366, no. 14, pp. 1298-309, 2012.
, “Refugee and migrant women's views of antenatal ultrasound on the Thai Burmese border: a mixed methods study”, PLoS ONE, vol. 7, no. 4, p. e34018, 2012.
, “Ultrasound evidence of early fetal growth restriction after maternal malaria infection”, PLoS ONE, vol. 7, no. 2, p. e31411, 2012.
, “Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand”, Malar J, vol. 10, p. 113, 2011.
, “Long-term humoral and cellular immune responses elicited by a heterologous Plasmodium vivax apical membrane antigen 1 protein prime/adenovirus boost immunization protocol”, Infect Immun, vol. 79, no. 9, pp. 3642-52, 2011.
, “Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria”, Antimicrob Agents Chemother, vol. 55, no. 9, pp. 4338-42, 2011.
, “A prospective study of urinary pneumococcal antigen detection in healthy Karen mothers with high rates of pneumococcal nasopharyngeal carriage”, BMC Infect Dis, vol. 11, p. 108, 2011.
, “A research agenda for malaria eradication: drugs”, PLoS Med, vol. 8, no. 1, p. e1000402, 2011.
, “First report of an Orientia tsutsugamushi type TA716-related scrub typhus infection in Thailand”, Vector Borne and Zoonotic Diseases, vol. 10, no. 2, pp. 191-3, 2010.
, “Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis”, Malar J, vol. 8, p. 203, 2009.
, “The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria”, Malar J, vol. 8, p. 207, 2009.
, “Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria”, Antimicrob Agents Chemother, vol. 53, no. 9, pp. 3837-46, 2009.
, “Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar”, Trop Med Int Health, vol. 13, no. 1, pp. 91-8, 2008.
, “How much fat is necessary to optimize lumefantrine oral bioavailability?”, Trop Med Int Health, vol. 12, no. 2. pp. 195-200, 2007.
, “A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia”, Trop Med Int Health, vol. 12, no. 2, pp. 251-9, 2007.
, “Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative”, PLoS Med, vol. 3, no. 6, p. e183, 2006.
, “Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison”, Lancet, vol. 367, no. 9528, pp. 2075-85, 2006.
, “The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria”, Eur J Clin Pharmacol, vol. 62, no. 12, pp. 1021-31, 2006.
, “Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria”, Antimicrob Agents Chemother, vol. 50, no. 7, pp. 2281-5, 2006.
, “Toxic brainstem encephalopathy after artemisinin treatment for breast cancer”, Ann Neurol, vol. 59, no. 4, pp. 725-6, 2006.
, “Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial”, Lancet, vol. 366, no. 9487, pp. 717-25, 2005.
, “Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria”, Antimicrob Agents Chemother, vol. 49, no. 4, pp. 1622-5, 2005.
, “Artesunate combinations for treatment of malaria: meta-analysis”, Lancet, vol. 363, no. 9402. pp. 9-17, 2004.
, “Inhibitory activities of sulfated proteoglycans on chondroitin sulfate A-mediated cytoadherence of Plasmodium falciparum isolates from Thailand”, Am J Trop Med Hyg, vol. 70, no. 2, pp. 149-57, 2004.
, “Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens”, Trans R Soc Trop Med Hyg, vol. 98, no. 3, pp. 182-92, 2004.
, “Central role of the spleen in malaria parasite clearance”, Journal of Infectious Diseases, vol. 185, no. 10, pp. 1538-41., 2002.
, “The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 2, pp. 180-4., 2002.
, “The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos”, Ann Trop Med Parasitol, vol. 96, no. 6, pp. 553-7, 2002.
, “Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil”, Clinical Infectious Diseases, vol. 35, no. 12, pp. 1498-504., 2002.
, “Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum”, Clinical Infectious Diseases, vol. 33, no. 12, pp. 2009-16., 2001.
, “Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission”, Am J Epidemiol, vol. 154, no. 5, pp. 459-65, 2001.
, “Factors contributing to anemia after uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 5, pp. 614-22., 2001.
, “Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 6, pp. 651-6., 2001.
, “Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy”, American Journal of Tropical Medicine and Hygiene, vol. 65, no. 4, pp. 285-9., 2001.
, “Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 545-8., 2000.
, “A case-control auditory evaluation of patients treated with artemisinin derivatives for multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 62, no. 1, pp. 65-9, 2000.
, “Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study”, Lancet, vol. 356, no. 9226, pp. 297-302, 2000.
, “Menorrhagia caused by dengue fever”, Australia and New Zealand Journal of Obstetrics and Gynaecology, vol. 40, no. 3, pp. 354-5., 2000.
, “Plasmodium falciparum antimalarial drug susceptibility on the north- western border of Thailand during five years of extensive use of artesunate-mefloquine”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 5, pp. 537-44., 2000.
, “Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 6, pp. 689-93., 2000.
, “Absence of an interaction between artesunate and atovaquone-proguanil”, European Journal of Clinical Pharmacology, vol. 55, no. 6, pp. 469-74, 1999.
, “Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria”, International Journal of Clinical Pharmacology and Therapeutics, vol. 37, no. 1, pp. 58-61, 1999.
, “The effects of mefloquine treatment in pregnancy”, Clinical Infectious Diseases, vol. 28, no. 4, pp. 808-15, 1999.
, “Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 936-42, 1999.
, “Genetic analysis of Plasmodium falciparum infections on the north- western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 6, pp. 587-93, 1999.
, “Meet my uncle”, Lancet, vol. 353, no. 9150, p. 414., 1999.
, “No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine”, American Journal of Tropical Medicine and Hygiene, vol. 61, no. 6, pp. 964-7, 1999.
, “Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria”, Antimicrob Agents Chemother, vol. 43, no. 2, pp. 341-6, 1999.
, “Population pharmacokinetics of mefloquine in patients with acute falciparum malaria”, Clinical Pharmacology and Therapeutics, vol. 66, no. 5, pp. 472-84, 1999.
, “Risk factors for gametocyte carriage in uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 1019-23, 1999.
, “The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy”, Annals of Tropical Medicine and Parasitology, vol. 93 Suppl 1, pp. S19-23., 1999.
, “Treatment of vivax malaria on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 93, no. 4, pp. 433-8, 1999.
, “Artemisinin derivatives in the treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 4, pp. 430-3., 1998.
, “Artesunate and mefloquine in the treatment of uncomplicated multidrug- resistant hyperparasitaemic falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 2, pp. 207-11, 1998.
, “Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 59, no. 6, pp. 883-8, 1998.
, “Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 1, pp. 45-9, 1998.
, “Maternal antibodies block malaria”, NATURE, vol. 395, no. 6705. pp. 851-2, 1998.
, “Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy”, Annals of Tropical Medicine and Parasitology, vol. 92, no. 6, pp. 643-53., 1998.
, “Randomized comparison of artemether-benflumetol and artesunate- mefloquine in treatment of multidrug-resistant falciparum malaria”, Antimicrob Agents Chemother, vol. 42, no. 1, pp. 135-9, 1998.
, “Smoking cheroots reduces birthweight”, Lancet, vol. 352, no. 9139, pp. 1521-2., 1998.
, “Thanaka (Limonia acidissima) and deet (di-methyl benzamide) mixture as a mosquito repellent for use by Karen women”, Medical and Veterinary Entomology, vol. 12, no. 3, pp. 295-301, 1998.
, “Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 5, pp. 574-7, 1997.
, “The epidemiology of severe malaria in an area of low transmission in Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 91, no. 3, pp. 256-62, 1997.
, “Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever”, Journal of Antimicrobial and Chemotherapy, vol. 40, no. 1, pp. 91-8, 1997.
, “Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast Asia”, Am J Trop Med Hyg, vol. 56, no. 5, pp. 526-32, 1997.
, “SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand”, Acta Tropica, vol. 67, no. 3, pp. 215-27, 1997.
, “Effects of artemisinin derivatives on malaria transmissibility”, Lancet, vol. 347, pp. 1654-8, 1996.
, “Electrocardiographic monitoring in severe falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 3. pp. 266-9, 1996.
, “The epidemiology of malaria in a Karen population on the western border of Thailand”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 2, pp. 105-11, 1996.
, “Mefloquine in infants and young children”, Annals of Tropical Paediatrics, vol. 16, no. 4, pp. 281-6, 1996.
, “Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand.”, Lancet, vol. 348, pp. 701-7, 1996.
, “Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 5, pp. 523-7, 1995.
, “Clinical features and outcome of severe malaria in Gambian children”, Clinical Infectious Diseases, vol. 21, no. 3, pp. 577-87, 1995.
, “Falciparum malaria in pregnancy”, Australia and New Zealand Journal of Obstetrics and Gynaecology, vol. 35, no. 4, pp. 468-9., 1995.
, “Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study”, PARASITOLOGY, vol. 110, no. Suppl. pp. S25-36, 1995.
, “Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients”, Bulletin of the World Health Organization, vol. 73, no. 5, pp. 631-42, 1995.
, “New antimalarials. A risk-benefit analysis”, DRUG SAFETY, vol. 12, no. 4, pp. 264-73, 1995.
, “Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins”, Parasite, vol. 2, no. 3, pp. 263-8, 1995.
, “Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 53, no. 5, pp. 522-5, 1995.
, “Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 6, pp. 660-4, 1995.
, “Mefloquine prophylaxis prevents malaria during pregnancy: a double- blind, placebo-controlled study”, Journal of Infectious Diseases, vol. 169, no. 3, pp. 595-603, 1994.
, “Bed nets for the prevention of malaria and anaemia in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 87, no. 6. pp. 620-6, 1993.
, “Cardiac effects of antimalarial treatment with halofantrine”, Lancet, vol. 341, pp. 1054-6, 1993.
, “Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria”, Lancet, vol. 341, pp. 1044-9, 1993.
, “Single dose pharmacokinetics of proguanil and its metabolites in pregnancy”, European Journal of Clinical Pharmacology, vol. 44, no. 3, pp. 247-51, 1993.
, “High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria”, Journal of Infectious Diseases, vol. 166, no. 6, pp. 1393-400, 1992.
, “Malaria during pregnancy in an area of unstable endemicity”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 85, no. 4, pp. 424-9, 1991.
, “Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria”, British Journal of Clinical Pharmacology, vol. 31, no. 5, pp. 556-9, 1991.
, “Mefloquine-resistant falciparum malaria on the Thai-Burmese border”, Lancet, vol. 337, no. 8750, pp. 1140-3, 1991.
, “Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study”, British Journal of Clinical Pharmacology, vol. 30, no. 1. pp. 79-85, 1990.
, “Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine”, Bulletin of the World Health Organization, vol. 65, no. 6. pp. 891-6, 1987.
,